1. India Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Global Health Limited

Global Health Limited

1,185.00
INR
-13.20
(-1.10%)
20.54EPS
63.46P/E
353.11BMarket Cap
Nov 06Next Earn
Global Health Limited
NSE:MEDANTA
(National Stock Exchange of India)

Recent

price

1,185.00

P/E

ratio

63.46

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
2026
TTM
INR
59.16
56.85
85.58
103.5
120.66
135.39
160.69
174.32
Revenue per Share
1.45
1.15
7.75
12.58
17.8
17.92
20.71
20.7
Basic EPS, GAAP
-0.53
3.82
1.45
15.76
12.42
-0.9
-9.83
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.5
- -
Dividend per Share
52.23
53.53
64.09
90.54
108.21
126.08
147.47
- -
Book Value per Share
51.89
53.24
63.84
90.35
108.01
125.66
146.87
- -
Tangible Book Value per Share
250
251
253
259
269
269
269
269
Basic Weighted Avg Shares
14,806
14,293
21,673
26,828
32,409
36,367
43,185
46,834
Sales/Revenue/Turnover
6.55
6.49
14.99
18.6
20.31
20.26
16.83
15.64
Operating Margin (%)
1,150
1,232
1,297
1,499
1,727
1,937
2,225
2,464
Depreciation Expense
363
288
1,962
3,261
4,782
4,814
5,565
5,562
Net Income, GAAP
43.12
11.27
30.07
27.42
23.77
25.64
22.51
23.3
Effective Tax Rate (%)
2.45
2.02
9.05
12.15
14.75
13.24
12.89
11.88
Profit Margin (%)
1,209
975
3,922
10,069
8,910
9,143
10,478
- -
Working Capital
8,758
8,284
10,033
9,826
6,300
6,235
11,271
- -
LT Debt
13,495
13,823
16,160
24,282
29,056
33,875
39,843
- -
Total Equity
- -
3.24
9.17
11.59
13.66
12.07
11.95
- -
Return on Invested Capital (%)
- -
3.85
9.99
12.18
14.71
13.55
13.35
- -
Return on Capital (%)
- -
2.16
13.23
16.13
17.93
15.3
15.15
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
630
- -
LT Borrowings
- -
6,011
- -
LT Finance Leases
- -
5,259
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
268
269
269
Market Capitalization
318,482
258,187
353,110

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
16,749
- -
Cash, Cash Equivalents & STI
- -
11,060
- -
Accounts Receivable, Net
- -
4,112
- -
Inventories
- -
790
- -
Total Current Liabilities
- -
6,271
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
630
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
24.21%
17.62%
Free Cash Flow
- -
363.39%
993.71%
Net Income, GAAP
- -
142.05%
15.58%
Sales/Revenue/Turnover
- -
25.44%
18.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
8,611
9,566
9,434
9,313
36,367
2026
10,308
10,992
11,210
11,590
43,185
2027
13,041
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3.96
4.87
5.32
3.77
17.92
2026
5.92
5.89
3.54
5.36
20.71
2027
5.91
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
0.5
2027
- -
- -
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
HCA Healthcare, Inc. (NYSE:HCA)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
Business
Global Health Limited (MEDANTA.NS) operates as a leading multi-specialty tertiary care provider under the Medanta brand, delivering advanced healthcare services across North and East India. The company offers comprehensive treatments in over 30 medical specialties, including cardiology and cardiac sciences; neurosciences; oncology; digestive and hepatobiliary sciences; orthopedics and musculoskeletal disorders; liver and kidney transplants; urology and nephrology; critical care and anesthesiology; endocrinology and diabetology; obstetrics and gynecology; dermatology; ophthalmology; dental care; ayurvedic medicine; as well as second opinion consultations, lab tests and diagnostics, homecare and elder care, telemedicine, air ambulance, and e-ICU services. It manages a network of hospitals in Gurugram, Indore, Ranchi, Lucknow, Patna, Noida, and Delhi, spanning 5.6 million square feet with 3,435 installed beds and over 2,000 doctors led by specialist department heads, targeting patients seeking high-end, affordable care in super-specialty segments. Founded in 2004 and headquartered in New Delhi, India, with its flagship Medanta - The Medicity facility in Gurgaon established in 2009, Global Health Limited focuses on centers of excellence in cardiac care, cancer care, neurosciences, gastrosciences, orthopedics, and renal care. In recent developments, the company launched a 550-bed super-specialty hospital in Noida on November 27, 2025, strengthening its National Capital Region footprint with metro connectivity to serve Delhi-NCR and Western Uttar Pradesh. It plans to add 550 beds in FY25 across Gurugram, Lucknow, Patna, and Noida; announced a 400-bed hospital in South Delhi with DLF and a 300-bed facility in Indore with a real estate partner; and acquired land in Mumbai's Oshiwara for a 500+ bed super-specialty hospital with a Rs 1,200 crore investment. As of Q1 FY25, revenue grew 11% year-over-year to INR 883 crore, driven by higher patient volumes, bed occupancy, and service realizations.